Cargando…
PKM2 Interacts With the Cdk1-CyclinB Complex to Facilitate Cell Cycle Progression in Gliomas
PKM2 is a phosphotyrosine-binding glycolytic enzyme upregulated in many cancers, including glioma, and contributes to tumor growth by regulating cell cycle progression. We noted, however, that in multiple glioma cell lines, PKM2 knock-down resulted in an accumulation of cells in G2-M phase. Moreover...
Autores principales: | Ohba, Shigeo, Tang, Yongjian, Johannessen, Tor-Christian Aase, Mukherjee, Joydeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981990/ https://www.ncbi.nlm.nih.gov/pubmed/35392228 http://dx.doi.org/10.3389/fonc.2022.844861 |
Ejemplares similares
-
CKAP2 phosphorylation by CDK1/cyclinB1 is crucial for maintaining centrosome integrity
por: Yoo, Bum Ho, et al.
Publicado: (2017) -
Human Immunodeficiency Virus Type 1 Vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrest
por: Sakai, Keiko, et al.
Publicado: (2011) -
Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma
por: Li, Hui, et al.
Publicado: (2023) -
Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo
por: Chen, Hua, et al.
Publicado: (2008) -
ESRRA promotes gastric cancer development by regulating the CDC25C/CDK1/CyclinB1 pathway via DSN1
por: Li, Feng-Nan, et al.
Publicado: (2021)